Prof. Helen Tremlett, PhD

Professor & Canada Research Chair in Neuroepidemiology and Multiple Sclerosis

Faculty of Medicine

Dept. of Medicine, Djavad Mowafaghian Centre for Brain Health

Vancouver Campus

Fields

Aging, Brain Dysfunction, Demographics, Health Care, Neuroscience / Cognitive Science, Pediatrics, Pharmaceuticals / Drugs, Public Health

Contact Information

Chosen name and pronouns:

Helen Tremlett (She/Her/Hers)

helen.tremlett@ubc.ca

Tel: 604-822-0759

http://epims.med.ubc.ca/

Media Contact

Erik Rolfsen

Media Relations Specialist

Tel: 604.822.2644

Cell: 604.209.3048

Email: erik.rolfsen@ubc.ca

Expertise

multiple sclerosis, epidemiology, pharmacoepidemiology, health administrative data, drug safety and effectiveness, disease-modifying drugs for multiple sclerosis, gut microbiome, pediatric-onset MS, observational studies, real-world data, post-marketing research,

In the Media

VIDEO: Growing body of literature supports existence of prodromal phase in MS – Healio Fatigue, Anemia, Pain, Sleep Disorders Found to Be Part of MS Prodrome – Neurology Advisor New findings suggests certain conditions are prevalent prior to MS symptom onset – CBH 4 Questions About Prodromal Multiple Sclerosis – Neurology Consultant360 Disability progression in multiple sclerosis linked to income, education Common treatment for multiple sclerosis may prolong life USA’s National MS Society: Landmark Study Estimates Nearly 1 Million in the U.S. Have Multiple Sclerosis